Entities / Company
Abbott Laboratories.
American global health care and medical device products company
- Reports this week
- 10
- Active events
- 11
- Connections
- 303
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Several investment firms increased or lifted their positions in Abbott Laboratories shares on October 20, 2026.Some support1 report
-
Market growth anticipated in Eastern Europe for Abbott Laboratories as of July 21, 2025.Some support1 report1 development inside
-
Abbott Laboratories faces an FDA recall classification of its sensors, while Ken Fisher and Donald Trump engage in stock transactions.Some support1 report
-
The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.Well supported7 reports
-
Abbott Laboratories and Medtronic plc operate within the healthcare device sector.Well supported7 reports1 development inside
-
Abbott Laboratories and Medtronic are both identified as dividend-paying stocks.Some support1 report
-
Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.Well supported11 reports1 development inside
-
The acquisition of Exact Sciences by Abbott Laboratories is weighing on Abbott's GAAP results.Some support1 report
-
Abbott Laboratories was featured as one of five stocks to watch on MarketBeat on May 26, 2026.Well supported16 reports
-
Investors are weighing established medical giants like Intuitive Surgical and Abbott Laboratories against high-growth specialists such as Lingo.Some support1 report
-
Corporate restructuring news includes the transformation of CORDIS from a division of Cardinal Health, the acquisitions of Guidant by Boston Scientific and Abbott Laboratories, and appointments involving Cirtec Medical.Some support2 reports3 developments inside
Earlier this month
-
Benchmark reduced its price target and set a buy rating for Abbott Laboratories, while Royal Bank of Canada issued an outperform rating on July 29, 2026.Some support3 reports
-
MarketBeat reported analyst ratings for ResMed and Abbott Laboratories on October 1, 2026.Some support1 report
-
Barclays rated Intuitive Surgical, GE Healthcare, and Abbott Laboratories as Overweight on October 7, 2026.Some support1 report
-
Abbott Laboratories and AT&T were recently mentioned in analyst upgrade and downgrade lists.Some support1 report
-
MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.Some support7 reports
-
Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Erie Indemnity.Some support3 reports
-
Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.Some support2 reports1 development inside
-
AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.Some support2 reports1 development inside
-
ExxonMobil and Abbott Laboratories are being discussed as high-dividend stocks suitable for retirees.Some support1 report
One to three months ago
-
Conavi Medical Corp. received FDA clearance for its system, which is used in the cardiovascular imaging sector.Some support1 report
-
Abbott Laboratories has facilities located in the states of Michigan and Arizona.Some support1 report
-
Abbott Laboratories is under investigation by the Justice Department regarding manufacturing and product recalls.Some support1 report
-
Product recalls and safety inquiries affect national formula supply following FDA oversight in Sturgis.Well supported19 reports
-
Market pressure due to cost trends is affecting major companies including UnitedHealth Group, Molina Healthcare, Abbott Laboratories, and Eli Lilly, as reported on Investopedia.Some support1 report6 developments inside
-
Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.Some support1 report
-
Nvidia and Abbott Laboratories are being discussed as a comparative market signal.Some support1 report
-
The Saudi Central Bank has increased its stake/position in Abbott Laboratories.Some support1 report
-
Companies including UnitedHealth Group, Procter & Gamble, Abbott Laboratories, and Merck are noted as being included in high-quality dividend ETFs.Some support1 report1 development inside
-
The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.Some support1 report
-
Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.Some support1 report
-
A Missouri appeals court upheld a verdict in a settlement case involving an Illinois mother, with federal cases consolidated in Chicago.Some support2 reports
-
Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.Some support2 reports1 development inside
-
Google Health and Abbott Laboratories are collaborating on a multiyear project to integrate Lingo CGM data.Some support2 reports
-
Thrivent Financial for Lutherans increased its stock position in Abbott Laboratories on August 15, 2026.Some support1 report
-
Cencora is identified as a wholesale distributor for AbbVie, while both AbbVie and Abbott Laboratories are noted as healthcare industry leaders.Some support4 reports
-
Abbott Laboratories and Amgen are major holdings in the SCHD ETF.Some support1 report
-
Meta's offerings are being improved by AI, while Foundry and Abbott Laboratories are noted as major AI platforms in global health/tech.Some support2 reports
Gone quiet
No new reports in 90+ days-
Trump DOJ declines to charge several corporations, signaling a softer approach to corporate crime.Some support1 report
-
Abbott Laboratories increased its stake in DHG Pharmaceutical to controlling interest (51.7 percent) in Việt Nam.Some support2 reports
-
Bank of America cut price objective and Daiwa Securities Group published research reports on Abbott Laboratories stock.Some support2 reports
-
Abbott Laboratories' stock surged +10.7% on July 17, 2026, while the S&P 500 index experienced a decline.Some support1 report
-
A representative made various stock transactions on July 18, 2026, including buying shares of Abbott Laboratories, Intercontinental Exchange, and L3Harris Technologies, while also selling shares of BlackRock, Analog Devices, and UnitedHealth Group. Truist Financial raised the L3Harris rating.Some support5 reports
-
A financial transaction involving stock sales between companies including Intuit, Procter & Gamble, S&P Global, and Abbott Laboratories.Some support1 report2 developments inside
-
Rick Larsen and MCK made stock transactions involving Amphenol, S&P Global, McKesson, and Abbott Laboratories on July 18, 2026.Some support5 reports
-
Abbott Laboratories and Analog Devices are publicly traded companies operating within the relevant sector.Some support2 reports
-
The iShares U.S. Medical Devices ETF holds significant shares of a medical device company.Some support3 reports
-
Josh Gottheimer made various stock transactions on July 9, 2026, including purchasing shares of Micron Technology and selling shares of Nintendo, Abbott Laboratories, Intuit, and Alibaba Group.Some support1 report
-
Invesco ETF holds significant shares of both Abbott Laboratories and AbbVie.Some support3 reports
-
Abbott Laboratories faces a nationwide infant formula recall and DOJ investigation following a cronobacter outbreak.Some support1 report
-
Abbott Laboratories and Mead Johnson are major manufacturers of infant formula.Some support9 reports
-
AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.Well supported11 reports
-
A luxury group is facing bankruptcy following a cybersecurity clampdown on a top U.S. AI, concurrent with the DOJ dropping charges against a company.Some support1 report
-
Abbott Laboratories is based in Illinois.Some support2 reports
-
Reuters reported on a federal judge's ruling involving Abbott Laboratories.Some support4 reports
-
Abbott Laboratories' market valuation and company strategy were discussed on CNBC.Some support1 report
-
Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.Some support2 reports
-
Abbott Laboratories and TerrAscend are competing for market share as medical companies.Some support6 reports
-
Citi reiterated a Buy rating on Abbott stock while BofA lowered its recommendation, amid tariffs benefiting AI stocks.Some support1 report
-
Products of Abbott Laboratories align with updated colorectal cancer screening guidelines.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Abbott Laboratories
Events traced to Abbott Laboratories, step by step, newest firstAround Abbott Laboratories this week
News at the entities that move Abbott Laboratories most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Abbott Laboratories
-
Food and Drug Administration StructuralFDA conducted a search operation in Pune on January 1, 2026.Moves Abbott Laboratories
-
SEC StructuralLaser Photonics Corporation hired Tim Peterman as Chief Financial Officer and engaged CBIZ for financial reporting consulting.Moves Abbott Laboratories
-
Securities and Exchange Commission StructuralNYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.Moves Abbott Laboratories
-
Johnson & Johnson OperationalFailures resulted in catastrophic reputational damage for several major companies, while others successfully used safety as a brand differentiator.Moves Abbott Laboratories
-
Donald Trump OperationalTrump allegedly ignored Graham's sanctions bill, slowed Starlink connections, and lifted sanctions to help Putin.Moves Abbott Laboratories
Connections
The 40 strongest of 303, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Exact Sciences Structural
Abbott Laboratories acquired Exact Sciences and integrated it as a subsidiary.
-
Sturgis Structural
A critical factory facility of Abbott Laboratories was located in Sturgis, producing a fifth of the national baby formula supply before a major contamination incident forced facility closure and product recall.
-
FDA Structural
The FDA regulates Abbott Laboratories, granting product approvals, setting operational standards, and conducting oversight.
-
Senseonics (United States) Transactional
Abbott Laboratories acquired shares in Senseonics through a private placement deal.
-
Johnson & Johnson Operational
Both companies are major healthcare giants that actively compete for market share through product innovation and strategic moves.
-
Food and Drug Administration Structural
The FDA exercises formal regulatory authority over Abbott Laboratories concerning product safety and facility operations.
-
Boston Scientific Operational
Abbott Laboratories and Boston Scientific are direct competitors in the medical devices industry, vying for market share through innovation and strategic moves.
-
Robert Ford Structural
Robert Ford holds the position of CEO at Abbott Laboratories.
Show all 40 connections
-
SEC Structural
Abbott operates under the mandatory filing and oversight requirements of the U.S. Securities and Exchange Commission (SEC).
-
AbbVie Operational
The companies are active competitors in the global healthcare products market, having historically been linked through a 2013 spin-off.
-
Europe Transactional
Abbott receives formula imports from Europe, often via airlift, to meet demand during shortages.
-
representative Transactional
Representative bought and sold shares of Abbott Laboratories.
-
Dexcom Operational
Dexcom and Abbott Laboratories are fierce competitors operating within the glucose monitoring market.
-
Mead Johnson Operational
Both companies are major competitors in the infant formula manufacturing industry.
-
ABR Operational
ABR provides brokerage recommendations calculated based on Abbott's stock performance and actively suggests buying the stock.
-
Volt Structural
Volt's systems are identified as a key confidence driver for Abbott Laboratories' operations.
-
Donald Trump Operational
Trump's political and regulatory actions influence Abbott Laboratories' business environment, while Abbott's value influences Trump's investment decisions.
-
Robert Ford Mentioned together
Robert Ford serves as the CEO of Abbott Laboratories, influencing its market outlook and operational direction.
-
Tandem Structural
Abbott Laboratories plans to integrate its offerings with Tandem's insulin pumps.
-
Missouri Structural
Abbott Laboratories is subject to the legal jurisdiction and appeals court system of Missouri.
-
Vijay Kumar Operational
Vijay Kumar, acting as a market analyst, issued a rating downgrade on Abbots Laboratories' stock.
-
Synlait Transactional
Abbott discussed acquiring Synlait's Pokeno facility, which was subsequently sold as part of a larger asset divestiture.
-
Google Health Operational
Google Health and Abbott Laboratories are engaged in a multiyear collaboration to integrate CGM data.
-
Manufacturers Life Insurance Company Structural
Manufacturers Life Insurance Company purchased a new stake in Abbott Laboratories stock, establishing an ownership relationship.
-
TD Cowen Mentioned together
TD Cowen provides investment ratings and target price analysis for Abbott Laboratories.
-
Eli Lilly and Company Operational
Abbott Laboratories and Eli Lilly and Company are major industry players engaged in active competition within the global pharmaceutical and healthcare products markets.
-
SPX Shared context
Abbott operates within the market context represented by the SPX index.
-
Stericycle Operational
The two companies are observed to be operating in a shared high-risk environment due to involvement in corporate crime issues.
-
Securities and Exchange Commission Structural
Abbott Laboratories operates under the regulatory oversight of the Securities and Exchange Commission, evidenced by required 13F filings.
-
Intuitive Surgical Operational
Both companies operate as peers and competitors within the healthcare equipment and supplies market.
-
Bank of America Operational
Bank of America actively tracks and adjusts price targets for Abbott Laboratories' stock.
-
Illinois Shared context
Abbott Laboratories operates and is subject to legal matters within the jurisdiction of Illinois.
-
Dublin Shared context
Abbott operates manufacturing sites and employs workers in Ireland, placing the company within the economic sphere of influence of Dublin.
-
Rick Larsen Transactional
Rick Larsen sold shares of Abbott Laboratories on July 18, 2026.
-
Medtronic plc Operational
Both Abbott and Medtronic are identified as key competitors and players within the healthcare device and tissue engineering markets.
-
Thermo Fisher Scientific Inc. Operational
The companies are major healthcare providers and compete in the market.
-
Lingo Structural
Abbott Laboratories integrates Lingo's glucose biowearable technology into its offerings for dietitians.
-
Ken Griffin Transactional
Ken Griffin purchased shares of Abbott Laboratories.
-
Ken Fisher Transactional
Ken Fisher's firm reduced its investment stake in Abbott Laboratories.
-
Las Vegas Sands Mentioned together
Both Las Vegas Sands and Abbott Laboratories were reported to be releasing earnings in the same week.
History
Events by the month they beganOctober 2026
8 events- Several investment firms increased or lifted their positions in Abbott Laboratories shares on October 20, 2026.
- Abbott Laboratories faces an FDA recall classification of its sensors, while Ken Fisher and Donald Trump engage in stock transactions.
- Abbott Laboratories and Medtronic are both identified as dividend-paying stocks.
- The acquisition of Exact Sciences by Abbott Laboratories is weighing on Abbott's GAAP results.
- Investors are weighing established medical giants like Intuitive Surgical and Abbott Laboratories against high-growth specialists such as Lingo.
- MarketBeat reported analyst ratings for ResMed and Abbott Laboratories on October 1, 2026.
- Barclays rated Intuitive Surgical, GE Healthcare, and Abbott Laboratories as Overweight on October 7, 2026.
- Abbott Laboratories and AT&T were recently mentioned in analyst upgrade and downgrade lists.
September 2026
8 events- ExxonMobil and Abbott Laboratories are being discussed as high-dividend stocks suitable for retirees.
- Conavi Medical Corp. received FDA clearance for its system, which is used in the cardiovascular imaging sector.
- Abbott Laboratories has facilities located in the states of Michigan and Arizona.
- Abbott Laboratories is under investigation by the Justice Department regarding manufacturing and product recalls.
- Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.
- Nvidia and Abbott Laboratories are being discussed as a comparative market signal.
- The Saudi Central Bank has increased its stake/position in Abbott Laboratories.
- The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.
August 2026
6 events- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- A Missouri appeals court upheld a verdict in a settlement case involving an Illinois mother, with federal cases consolidated in Chicago.
- Google Health and Abbott Laboratories are collaborating on a multiyear project to integrate Lingo CGM data.
- Thrivent Financial for Lutherans increased its stock position in Abbott Laboratories on August 15, 2026.
- Cencora is identified as a wholesale distributor for AbbVie, while both AbbVie and Abbott Laboratories are noted as healthcare industry leaders.
- Abbott Laboratories and Amgen are major holdings in the SCHD ETF.
Show 2 earlier months
July 2026
15 events- The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.
- Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.
- Benchmark reduced its price target and set a buy rating for Abbott Laboratories, while Royal Bank of Canada issued an outperform rating on July 29, 2026.
- Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.
- Trump DOJ declines to charge several corporations, signaling a softer approach to corporate crime.
- Abbott Laboratories increased its stake in DHG Pharmaceutical to controlling interest (51.7 percent) in Việt Nam.
- Bank of America cut price objective and Daiwa Securities Group published research reports on Abbott Laboratories stock.
- Abbott Laboratories' stock surged +10.7% on July 17, 2026, while the S&P 500 index experienced a decline.
- A representative made various stock transactions on July 18, 2026, including buying shares of Abbott Laboratories, Intercontinental Exchange, and L3Harris Technologies, while also selling shares of BlackRock, Analog Devices, and UnitedHealth Group. Truist Financial raised the L3Harris rating.
- Rick Larsen and MCK made stock transactions involving Amphenol, S&P Global, McKesson, and Abbott Laboratories on July 18, 2026.
- Abbott Laboratories and Analog Devices are publicly traded companies operating within the relevant sector.
- Josh Gottheimer made various stock transactions on July 9, 2026, including purchasing shares of Micron Technology and selling shares of Nintendo, Abbott Laboratories, Intuit, and Alibaba Group.
- Invesco ETF holds significant shares of both Abbott Laboratories and AbbVie.
- Abbott Laboratories faces a nationwide infant formula recall and DOJ investigation following a cronobacter outbreak.
- Abbott Laboratories and Mead Johnson are major manufacturers of infant formula.
June 2026
23 events- Market growth anticipated in Eastern Europe for Abbott Laboratories as of July 21, 2025.
- Abbott Laboratories and Medtronic plc operate within the healthcare device sector.
- Abbott Laboratories was featured as one of five stocks to watch on MarketBeat on May 26, 2026.
- Corporate restructuring news includes the transformation of CORDIS from a division of Cardinal Health, the acquisitions of Guidant by Boston Scientific and Abbott Laboratories, and appointments involving Cirtec Medical.
- MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Erie Indemnity.
- AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.
- Product recalls and safety inquiries affect national formula supply following FDA oversight in Sturgis.
- Market pressure due to cost trends is affecting major companies including UnitedHealth Group, Molina Healthcare, Abbott Laboratories, and Eli Lilly, as reported on Investopedia.
- Companies including UnitedHealth Group, Procter & Gamble, Abbott Laboratories, and Merck are noted as being included in high-quality dividend ETFs.
- Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.
- Meta's offerings are being improved by AI, while Foundry and Abbott Laboratories are noted as major AI platforms in global health/tech.
- A financial transaction involving stock sales between companies including Intuit, Procter & Gamble, S&P Global, and Abbott Laboratories.
- The iShares U.S. Medical Devices ETF holds significant shares of a medical device company.
- AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
- A luxury group is facing bankruptcy following a cybersecurity clampdown on a top U.S. AI, concurrent with the DOJ dropping charges against a company.
- Abbott Laboratories is based in Illinois.
- Reuters reported on a federal judge's ruling involving Abbott Laboratories.
- Abbott Laboratories' market valuation and company strategy were discussed on CNBC.
- Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.
- Abbott Laboratories and TerrAscend are competing for market share as medical companies.
- Citi reiterated a Buy rating on Abbott stock while BofA lowered its recommendation, amid tariffs benefiting AI stocks.
- Products of Abbott Laboratories align with updated colorectal cancer screening guidelines.